Loading…
Avanos Medical, Inc. is projected to rise to $30.08 by 2027, a +21% move from its current price of $24.79. AVNS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $24.54 | $24.79 | $25.05 | +0.01% |
| May 30 | $24.43 | $24.80 | $25.16 | +0.02% |
| May 31 | $24.36 | $24.80 | $25.25 | +0.04% |
| Jun 1 | $24.29 | $24.80 | $25.32 | +0.05% |
| Jun 2 | $24.24 | $24.80 | $25.39 | +0.06% |
| Jun 3 | $24.19 | $24.81 | $25.45 | +0.07% |
| Jun 4 | $24.14 | $24.81 | $25.50 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.14 | $24.81 | $25.50 | +0.08% |
| Week 2 | $23.89 | $24.83 | $25.81 | +0.17% |
| Week 3 | $23.70 | $24.85 | $26.06 | +0.25% |
| Week 4 | $23.54 | $24.87 | $26.27 | +0.33% |
| Week 5 | $23.41 | $24.89 | $26.47 | +0.41% |
| Week 6 | $23.29 | $24.91 | $26.64 | +0.50% |
| Week 7 | $23.19 | $24.93 | $26.81 | +0.58% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Avanos Medical, Inc. is a medical technology company that provides medical device solutions across North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its digestive health products include Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
The company also offers non-opioid pain solutions, including surgical pain and recovery products such as ON-Q and ambIT surgical pain pump, Game Ready cold and compression therapy systems. In addition, it provides interventional pain solutions with COOLIEF chronic pain products and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. Avanos markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.
Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
The stock trades under the symbol AVNS. The current price is $24.61 with a market cap of $1.15B, and it is ranked 2434 by market capitalization.
The 30-day forecast for 2026 shows a min of $11.18, an avg of $24.61, and a max of $34.32, with an ROI of 0% and a Neutral sentiment. This suggests a neutral near-term outlook around today’s price and potential volatility within a broad range.
Looking further ahead, the forecasts indicate bullish momentum beyond 2026, with rising averages and higher ROIs: 2027 avg $30.38 (ROI 23.4%), 2028 avg $35.11 (ROI 42.7%), 2029 avg $38.42 (ROI 56.1%), 2030 avg $41.63 (ROI 69.2%), 2031 avg $53.32 (ROI 116.7%), 2032 avg $62.29 (ROI 153.1%), 2033 avg $67.62 (ROI 174.8%), 2034 avg $76.36 (ROI 210.3%), 2035 avg $80.10 (ROI 225.5%), 2040 avg $133.93 (ROI 444.2%), and 2050 avg $255.00 (ROI 936.2%). The sentiment is labeled bullish for the longer horizon.
A major floor 50.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 0.6% above — clearing it would confirm fresh momentum.
Key AVNS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AVNS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.72 | Buy | $24.74 | Buy |
| MA 10 | $24.72 | Buy | $24.71 | Buy |
| MA 20 | $24.72 | Buy | $24.23 | Buy |
| MA 50 | $20.55 | Buy | $21.51 | Buy |
| MA 100 | $17.00 | Buy | $18.51 | Buy |
| MA 200 | $14.28 | Buy | $16.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 83.38 | Sell |
| Stoch RSI (14) | 19.18 | Buy |
| CCI (20) | 112.40 | Buy |
| Williams %R (14) | -10.00 | Info |
| MACD (12,26,9) | -0.33 | Sell |
| ROC (12) | -0.04 | Sell |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 90.00 | Sell |
| TRIX (15) | 0.86 | Buy |
| Awesome (5,34) | 0.94 | Buy |
| Ultimate (7,14,28) | 59.17 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 24.71 | Buy |
| ADX (14) | 68.69 | Buy |
| ATR (14) | 0.13 | Info |
The 30-day technical picture is bullish, supported by RSI14 at 80. This suggests strong momentum and potential overbought conditions.
The stock’s short-term technicals show the 50-day simple moving average at $20.11 and the 200-day simple moving average at $14.14. Key levels to watch are a support at $14.53 and a resistance at $24.81. The 30-day trading range spans from $22.90 to $26.45.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.18 | $24.79 | $34.26 | 0% | Neutral | |
| $24.57 | $30.08 | $38.54 | +21% | Bullish | |
| $27.50 | $34.27 | $45.06 | +38% | Bullish | |
| $29.43 | $37.24 | $49.98 | +50% | Bullish | |
| $31.10 | $39.87 | $54.46 | +61% | Bullish | |
| $38.64 | $50.14 | $69.55 | +102% | Bullish | |
| $44.77 | $58.74 | $82.63 | +137% | Bullish | |
| $47.98 | $63.62 | $90.63 | +157% | Bullish | |
| $52.90 | $70.84 | $102.12 | +186% | Bullish | |
| $55.14 | $74.53 | $108.62 | +201% | Bullish | |
| $86.15 | $121.43 | $185.41 | +390% | Bullish | |
| $150.83 | $227.96 | $373.00 | +820% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $11.18 | $24.79 | $29.02 | +0.00% |
| June 2026 | $21.17 | $24.69 | $29.36 | -0.40% |
| July 2026 | $21.36 | $25.06 | $30.08 | +1.49% |
| August 2026 | $21.94 | $25.85 | $31.26 | +3.17% |
| September 2026 | $21.91 | $25.92 | $31.53 | +0.27% |
| October 2026 | $21.83 | $25.92 | $31.69 | -0.03% |
| November 2026 | $22.55 | $26.84 | $32.98 | +3.59% |
| December 2026 | $23.25 | $27.76 | $34.26 | +3.42% |
Click any year to see its month-by-month AVNS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The AVNS price prediction for 2026 points to an average of $24.79 (low $11.18, high $34.26) — a potential gain of 0% on today's $24.79. A consolidation phase looks the most probable path here.
In 2027, AVNS is projected to trade between $24.57 and $38.54, averaging $30.08 — a potential gain of +21% from today's $24.79. That is up +21% on the projected 2026 average. Momentum favours further upside here.
Avanos Medical, Inc.'s 2028 outlook centres on $34.27, within a $27.50 to $45.06 range. That is up +14% on the projected 2027 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, AVNS could reach as high as $49.98, with a base case around $37.24 and support toward $29.43 — roughly +50% from $24.79. Momentum favours further upside here.
Expect AVNS to range from $31.10 to $54.46 through 2030. The $39.87 average target implies a +61% move from current prices. That is up +7% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The AVNS price prediction for 2031 points to an average of $50.14 (low $38.64, high $69.55) — a potential gain of +102% on today's $24.79. Momentum favours further upside here.
In 2032, AVNS is projected to trade between $44.77 and $82.63, averaging $58.74 — a potential gain of +137% from today's $24.79. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Avanos Medical, Inc.'s 2033 outlook centres on $63.62, within a $47.98 to $90.63 range. That is up +8% on the projected 2032 average. That marks a +157% change versus current levels. Momentum favours further upside here.
By 2034, AVNS could reach as high as $102.12, with a base case around $70.84 and support toward $52.90 — roughly +186% from $24.79. Buyers look set to stay in control over this stretch.
Expect AVNS to range from $55.14 to $108.62 through 2035. The $74.53 average target implies a +201% move from current prices. That is up +5% on the projected 2034 average. Momentum favours further upside here.
The AVNS price prediction for 2040 points to an average of $121.43 (low $86.15, high $185.41) — a potential gain of +390% on today's $24.79. Buyers look set to stay in control over this stretch.
In 2050, AVNS is projected to trade between $150.83 and $373.00, averaging $227.96 — a potential gain of +820% from today's $24.79. That is up +88% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in AVNS today (≈ 40.338846 AVNS) could be worth
$9,195.61
+$8,195.61 (+820%) by 2050 · US Dollar
Based on the average projected AVNS price of $227.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AVNSwould be worth at today's price.
$1,000 invested in AVNS on May 27, 2025 (≈ 78.124999 AVNS) would be worth
$1,936.72
+$936.72 (+93.7%) today · 1.94× · US Dollar
Based on a AVNS entry price of $12.8 vs. today's $24.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.74 | $1,002.02 | +0.2% |
| 1 month ago | $24.62 | $1,006.9 | +0.7% |
| 3 months ago | $14.49 | $1,710.84 | +71.1% |
| 6 months ago | $11.74 | $2,111.58 | +111.2% |
| 1 year ago | $12.8 | $1,936.72 | +93.7% |
| All time (5.0y) ago | $40.25 | $615.9 | -38.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AVNS forecast.
Our base-case forecast reaches $50.00 around 2031.
Implied market cap at $50.00: $2.34B
The multi-year forecast portrays a growth trajectory beyond 2026, starting with a 2026 min of $11.18, an avg of $24.61, and a max of $34.32 (ROI 0) with a Neutral sentiment.
By 2030 the forecast shows an avg of $41.63 with a 69.2% ROI and a bullish sentiment, indicating meaningful upside from today’s price. The long-range view continues to be positive, with the 2040 forecast at an avg of $133.93 and a 444.2% ROI, and the 2050 forecast at an avg of $255.00 with a 936.2% ROI, both labeled bullish. These figures illustrate a broad and substantial potential appreciation over time, while recognizing they are estimates, not guarantees.
Tap a question to reveal the answer.
2030 min is $32.46, avg is $41.63, max is $56.87, with an ROI of 69.2% and sentiment BULLISH.
The forecast shows a bullish sentiment for 2027–2050, with rising averages and ROIs: 2027 avg $30.38 (ROI 23.4%), 2028 avg $35.11 (ROI 42.7%), 2030 avg $41.63 (ROI 69.2%), 2040 avg $133.93 (ROI 444.2%), and 2050 avg $255.00 (ROI 936.2%). 2026 is Neutral with an avg of $24.61.
Yes—the 2040 max is $204.52, and the 2040 avg is $133.93, indicating potential above $100 within that horizon.
RSI14 is 80, indicating bullish strength. The 50-day SMA is $20.11 and the 200-day SMA is $14.14, with a support at $14.53 and a resistance at $24.81. The 30-day range is $22.90 to $26.45.
Current price is $24.61 and the market cap is $1.15B; the rank is 2434.
Avanos Medical, Inc. Community Discussion
0Share your Avanos Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.